630 related articles for article (PubMed ID: 17669103)
1. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
2. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
3. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
5. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
Hurduc V; Plesca D; Dragomir D; Sajin M; Vandenplas Y
Acta Paediatr; 2009 Jan; 98(1):127-31. PubMed ID: 18681892
[TBL] [Abstract][Full Text] [Related]
6. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
8. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Nista EC; Candelli M; Cremonini F; Cazzato IA; Zocco MA; Franceschi F; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1181-8. PubMed ID: 15569121
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
10. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
13. The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori.
Song MJ; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Helicobacter; 2010 Jun; 15(3):206-13. PubMed ID: 20557362
[TBL] [Abstract][Full Text] [Related]
14. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
[TBL] [Abstract][Full Text] [Related]
16. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
18. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
[TBL] [Abstract][Full Text] [Related]
19. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
